Autek China Inc (300595) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.031x

Based on the latest financial reports, Autek China Inc (300595) has a cash flow conversion efficiency ratio of 0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.20 Million ≈ $24.90 Million USD) by net assets (CN¥5.45 Billion ≈ $797.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300595 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Autek China Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Autek China Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Autek China Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autek China Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Chengdu ALD Aviation Manufacturing Corp
SHE:300696
-0.006x
REX American Resources Corporation
NYSE:REX
-0.003x
Azad Engineering Limited
NSE:AZAD
-0.050x
Immunocore Holdings Ltd
NASDAQ:IMCR
-0.011x
Guangdong Yizumi Precision Machinery Co Ltd
SHE:300415
-0.008x
FMC Corporation
NYSE:FMC
0.303x
Blackrock Municipal Target Term Closed Fund
NYSE:BTT
0.018x
Bilia AB (publ)
ST:BILI-A
0.122x

Annual Cash Flow Conversion Efficiency for Autek China Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Autek China Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Autek China Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.45 Billion
≈ $797.38 Million
CN¥827.38 Million
≈ $121.07 Million
0.152x +14.03%
2024-12-31 CN¥5.14 Billion
≈ $752.68 Million
CN¥684.91 Million
≈ $100.22 Million
0.133x -13.28%
2023-12-31 CN¥4.71 Billion
≈ $689.38 Million
CN¥723.38 Million
≈ $105.85 Million
0.154x +8.27%
2022-12-31 CN¥4.60 Billion
≈ $672.46 Million
CN¥651.72 Million
≈ $95.37 Million
0.142x -42.92%
2021-12-31 CN¥2.54 Billion
≈ $371.11 Million
CN¥630.09 Million
≈ $92.20 Million
0.248x +29.87%
2020-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥380.94 Million
≈ $55.74 Million
0.191x -0.11%
2019-12-31 CN¥1.44 Billion
≈ $210.40 Million
CN¥275.37 Million
≈ $40.29 Million
0.192x +39.58%
2018-12-31 CN¥1.08 Billion
≈ $158.39 Million
CN¥148.52 Million
≈ $21.73 Million
0.137x -22.98%
2017-12-31 CN¥812.34 Million
≈ $118.87 Million
CN¥144.71 Million
≈ $21.18 Million
0.178x -48.27%
2016-12-31 CN¥315.94 Million
≈ $46.23 Million
CN¥108.80 Million
≈ $15.92 Million
0.344x +8.82%
2015-12-31 CN¥253.53 Million
≈ $37.10 Million
CN¥80.23 Million
≈ $11.74 Million
0.316x -1.81%
2014-12-31 CN¥192.08 Million
≈ $28.11 Million
CN¥61.91 Million
≈ $9.06 Million
0.322x -11.92%
2013-12-31 CN¥145.86 Million
≈ $21.34 Million
CN¥53.37 Million
≈ $7.81 Million
0.366x +100.78%
2012-12-31 CN¥105.24 Million
≈ $15.40 Million
CN¥19.18 Million
≈ $2.81 Million
0.182x --

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.44 Billion
CN¥9.87 Billion CNY
Market Cap Rank
#7528 Global
#1749 in China
Share Price
CN¥11.02
Change (1 day)
-1.52%
52-Week Range
CN¥10.97 - CN¥19.38
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more